Stefan Mereiter
Impact in
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research
- Extracellular vesicles in disease
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- Glycosylation and Glycoproteins Research 21
- Metabolomics and Mass Spectrometry Studies 2
-
- SARS-CoV-2 and COVID-19 Research 2
- Tuberculosis Research and Epidemiology 2
- Co-authors
- Celso Albuquerque Reis (22 shared papers)Meritxell Balmaña (9 shared papers)Joana Gomes (9 shared papers)Diana Campos (3 shared papers)Ana Magalhães (9 shared papers)Catarina Gomes (4 shared papers)Joana A. Macedo (3 shared papers)Julio Cesar Madureira de‐Freitas‐Junior (1 shared paper)
In The Last Decade
Stefan Mereiter
34 papers receiving 1.4k citations
Stefan Mereiter's Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 894
- Infectious Diseases 116
- Cell Biology 74
- Oncology 116
- Immunology 72
Countries citing papers authored by Stefan Mereiter
This map shows the geographic impact of Stefan Mereiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Mereiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Mereiter more than expected).
Fields of papers citing papers by Stefan Mereiter
This network shows the impact of papers produced by Stefan Mereiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Mereiter. The network helps show where Stefan Mereiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Mereiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading? Hit paper breakdown → | 2019 | 439 |
| 2 | 2018 | 194 | |
| 3 | 2019 | 79 | |
| 4 | 2021 | 59 | |
| 5 | 2016 | 56 | |
| 6 | 2015 | 55 | |
| 7 | 2021 | 53 | |
| 8 | 2021 | 52 | |
| 9 | 2022 | 44 | |
| 10 | 2019 | 38 | |
| 11 | 2018 | 33 | |
| 12 | 2017 | 31 | |
| 13 | 2020 | 27 | |
| 14 | 2020 | 25 | |
| 15 | 2017 | 24 | |
| 16 | 2020 | 23 | |
| 17 | 2017 | 21 | |
| 18 | 2018 | 21 | |
| 19 | 2018 | 20 | |
| 20 | 2020 | 18 |
About Stefan Mereiter
Stefan Mereiter is a scholar working on Molecular Biology, Infectious Diseases, Cell Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (21 papers), Proteoglycans and glycosaminoglycans research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Renal cell carcinoma treatment (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Microfluidic and Bio-sensing Technologies (2 papers). The work is most often cited by research in Molecular Biology (894 citations), Infectious Diseases (116 citations), Cell Biology (74 citations), Oncology (116 citations) and Immunology (72 citations). Stefan Mereiter has collaborated with scholars based in Portugal, Austria and Sweden. Frequent co-authors include Celso Albuquerque Reis, Meritxell Balmaña, Joana Gomes, Diana Campos, Ana Magalhães, Catarina Gomes, Joana A. Macedo, Julio Cesar Madureira de‐Freitas‐Junior, Ângela Fernandes and Juliana Poças. Their work appears in journals such as International Journal of Molecular Sciences, EMBO Molecular Medicine, Glycobiology, Nature Communications and New Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.